Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government.
Related Keywords
, Pfizer , Wall Street , Earnings Reports , Earnings , Health Care Industry , Pharmaceuticals , Biotech And Pharmaceuticals , Biotechnology , Business , Pfizer Inc , Spin Offs , Seagen Inc , Business News ,
vimarsana.com © 2020. All Rights Reserved.